MITRA BE0974283153

Rapport

Real Time Euronext Bruxelles - 26/05 17:35:03 CEST
7.060	EUR		-1.67%

16/05	Degroof Petercam verlaagt koersdoel Mithra	AM
13/05	Mithra haalt geld op bij LDA Capital	AM
12/05	Mithra presenteert studieresultaten met Donesta	AM

Nieuws

Persberichten

Officiële publicaties

Sectornieuws

Analyse MarketScreener

Communiqués de presse de la société MITHRA PHARMACEUTICALS S.A.

16/05	Mithra Issues a Put Option Notice Under Capital Agreement with LDA Capital	AQ
09/05	Mithra - Publication of a Transparency Notification Received from Glenernie Capital	AQ
02/05	Mithra - Publication of Transparency Notifications Received from Goldman Sachs	AQ
26/04	MITHRA PHARMACEUTICALS S A : CDMO Announces Collaboration with MedinCell for the Developme..	PU
20/04	Mithra Releases Invitation to its General Ordinary and Extraordinary Securities holders..	AQ
19/04	MITHRA PHARMACEUTICALS S A : Releases Invitation to its General Ordinary and Extraordinary..	PU
18/04	Mithra Releases 2021 Annual Report	AQ
18/04	MITHRA PHARMACEUTICALS S A : Announces the Extension of the Capital Commitment Agreement w..	PU
15/04	MITHRA PHARMACEUTICALS : Releases 2021 Annual Report	PU
14/04	Mithra Announces Improved Consolidated Topline Results from Donesta Phase 3 Studies and..	AQ
14/04	MITHRA PHARMACEUTICALS S A : Announces Improved Consolidated Topline Results from Donesta®..	PU
08/04	MITHRA PHARMACEUTICALS S A : Publication of a Transparency Notification Received from Gold..	PU
29/03	MITHRA PHARMACEUTICALS S A : Publication of a Transparency Notification Received from Fran..	PU
29/03	MITHRA PHARMACEUTICALS S A : Publication of a Transparency Notification Received from Gold..	PU
24/03	Mithra - Publication of a Transparency Notification Received from Goldman Sachs	AQ
23/03	MITHRA PHARMACEUTICALS S A : Publication of a Transparency Notification Received from Gold..	PU
21/03	MITHRA PHARMACEUTICALS S A : Exercise of a Second Drawing Request under Equity Funding Agr..	PU
08/03	MITHRA PHARMACEUTICALS S A : Reports Full Year 2021 Financial Results	PU
01/03	Mithra - Publication of a Transparency Notification Received from Francois Fornieri	AQ
28/02	Mithra - Publication of a Transparency Notification Received from Alychlo	AQ
28/02	Mithra - Publication of a Transparency Notification Received from Goldman Sachs	AQ
25/02	MITHRA PHARMACEUTICALS S A : Publication of a Transparency Notification Received from Gold..	PU
17/02	Mithra and Searchlight Pharma Announce Launch of Haloette in Canada	AQ
17/02	Mithra - Publication of a Transparency Notification Received from Francois Fornieri	AQ
07/02	MITHRA PHARMACEUTICALS S A : Obtains Equity Funding for up to EUR 100 Million	PU
17/01	Mithra Announces Positive Top-Line Results	AQ
14/01	MITHRA PHARMACEUTICALS S A : Announces Positive Top-Line Results from Donesta® Phase 3 Stu..	PU
11/01	Publication of a Transparency Notification Received from Francois Fornieri	AQ
10/01	MITHRA PHARMACEUTICALS S A : Publication of a Transparency Notification Received from Fran..	PU
2021	MITHRA PHARMACEUTICALS S A : Issues a Put Option Notice Under Capital Agreement with LDA C..	PU
2021	Mayne pharma and mithra announce tga approval of nextstellis oral contraceptive	AQ
2021	MITHRA PHARMACEUTICALS S A : Mayne Pharma and Mithra Announce TGA Approval of Nextstellis®..	PU
2021	MITHRA PHARMACEUTICALS S A : holds today its Investor Day at CDMO	PU
2021	Mithra organizes its Investor Day on November 29, 2021	PU
2021	MITHRA PHARMACEUTICALS S A : Announces Estelle Launch in Belgium	AQ
2021	MITHRA PHARMACEUTICALS S A : Announces Estelle® Launch in Belgium	PU
2021	MITHRA PHARMACEUTICALS S A : The Board of Directors confirms Leon Van Rompay as Mithra's C..	PU
2021	MITHRA PHARMACEUTICALS S A : Provides FDA Update on Myring	AQ
2021	MAYNE PHARMA : Provides fda update on generic nuvaringo	AQ
2021	MITHRA PHARMACEUTICALS S A : Provides FDA Update on Myring®	PU
2021	MITHRA PHARMACEUTICALS S A : Announces the Appointment of its Representative to Mayne Phar..	AQ
2021	MITHRA PHARMACEUTICALS S A : Announces the Appointment of its Representative to Mayne Phar..	PU
2021	MITHRA PHARMACEUTICALS S A : Announces Topline Results for COVID-19 Phase II Study	AQ
2021	MITHRA PHARMACEUTICALS S A : Announces Topline Results for COVID-19 Phase II Study	PU
2021	MITHRA PHARMACEUTICALS S A : Interim Financial Report as at 30 June 2021	PU
2021	MITHRA PHARMACEUTICALS S A : Announces 2021 Half Year Results	PU
2021	MITHRA PHARMACEUTICALS S A : Half Year 2021 Results	PU
2021	MITHRA PHARMACEUTICALS S A : Announces an Update on PeriNesta	AQ
2021	MITHRA PHARMACEUTICALS S A : Announces an Update on PeriNesta®	PU
2021	DONESTA® PHASE III : Recruitment Completion of American Study and Additional Recruitment i..	PU
2021	MITHRA PHARMACEUTICALS S A : to Host Webcast for Half Year Financial Results on 24 Septemb..	PU
2021	MITHRA PHARMACEUTICALS S A : Announces Estelle® Approval in Russia	PU
2021	MITHRA PHARMACEUTICALS S A : and Searchlight Pharma Announce Availability of Nextstellis® ..	PU
2021	MITHRA PHARMACEUTICALS S A : extends the pricing period for the put option announced on Ju..	PU
2021	MITHRA PHARMACEUTICALS S A : ExeVir and Mithra announce manufacturing collaboration for in..	PU
2021	MITHRA PHARMACEUTICALS S A : Issues a Put Option Notice Under Capital Agreement with LDA C..	AQ
2021	MITHRA PHARMACEUTICALS S A : Issues a Put Option Notice Under Capital Agreement with LDA C..	PU
2021	MITHRA PHARMACEUTICALS S A : successfully renegotiates the earnouts relating to its Comple..	AQ
2021	MITHRA PHARMACEUTICALS S A : successfully renegotiates the earnouts relating to its Comple..	PU
2021	Estelle Oral Contraceptive Now Available In the United States	AQ
2021	MITHRA PHARMACEUTICALS : Estelle® Oral Contraceptive Now Available In The United States	PU
2021	Mayne - Nextstellis Receives FDA Marketing Exclusivity And Phase III Data Published	AQ
2021	MAYNE PHARMA : Nextstellis receives fda marketing exclusivity and phase iii data published	AQ
2021	MITHRA PHARMACEUTICALS S A : Nextstellis® Receives FDA Marketing Exclusivity and Phase III..	PU
2021	MITHRA PHARMACEUTICALS S A : Announces European Approval of Estelle	AQ
2021	MITHRA PHARMACEUTICALS S A : Announces European Approval of Estelle®	PU
2021	MITHRA PHARMACEUTICALS S A : takes note of François Fornieri's indictment	PU
2021	MITHRA PHARMACEUTICALS S A : Releases 2020 Annual Report and Invitation to its Securities ..	AQ
2021	MITHRA PHARMACEUTICALS S A : Releases 2020 Annual Report and Invitation to its Securities ..	PU
2021	MITHRA PHARMACEUTICALS S A : Transparency Notification from Alychlo NV	PU
2021	MITHRA PHARMACEUTICALS S A : Publication of a Transparency Notification Received from Alyc..	PU
2021	MAYNE PHARMA : And mithra announce fda approval of new oral contraceptive nextstellis	AQ
2021	Mayne Pharma and Mithra Announce FDA Approval of New Oral Contraceptive Estelle	AQ
2021	Richter and Mithra Receive Positive CHMP Opinion for Estelle	AQ
2021	MITHRA PHARMACEUTICALS S A : Richter and Mithra Receive Positive CHMP Opinion for Estelle®	PU

1 2 3 4 5 Volgende

Analyse

Mithra meldt betere resultaten voor Donesta

Meer diepgaande analyses

Officiële publicaties

29/04	Crossing thresholds
29/04	Crossing thresholds
19/04	Report
19/04	Auditors Report
19/04	Auditors Report
18/04	Mixed general shareholder meeting

Meer Officiële publicaties

Volgende evenement op MITHRA PHARMACEUTICALS S.A.

23/09/22

Eerste halfjaar 2022 Cijferpublicaties

De agenda van het bedrijf

Komende gebeurtenissen in de sector

26/07/22	BIOGEN INC. : Eerste halfjaar 2022 Cijferpublicaties (schatting)
16/08/22	SAMSUNG BIOLOGICS CO.,LTD. : Eerste halfjaar 2022 Cijferpublicaties (schatting)
17/08/22	CSL LIMITED : Boekjaar 2022 Cijferpublicaties
22/08/22	WUXI BIOLOGICS (CAYMAN) INC. : Eerste halfjaar 2022 Cijferpublicaties (schatting)

Meer evenementen

Sector

Gezondheidszorg
	Farmaceutisch en medisch onderzoek
		Farmaceutische producten
			Farmaceutische producten
				Biofarmaceutica